The world’s No. 2 cigarette maker is currently awaiting approval from the U.S. Food and Drug Administration to proceed with Phase 1 trials. Read More
Health body says studies suggesting benefits were not designed to evaluate whether smoking is protective.Read More
Critics point to shortcomings in studies suggesting protective properties against the virus. Read More
Non-GMO methodologies can be applied reliably to reduce nicotine levels in tobacco plants by up to 99 percentRead More
New hires will strengthen support for companies in the ENDS sector.Read More
The scientific evidence is clear that nicotine itself is not responsible for smoking-related diseases.Read More
Anti-vaping activist groups may be causing more deaths with false rhetoric.Read More
French study suggests nicotine may protect against Covid-19.Read More
Coresta on Track for ViennaRead More
Claims About Smoking and Covid-19 ExaminedRead More